| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |